Response in the placebo group in randomized controlled trials for moderate-to-severe psoriasis

被引:0
|
作者
Afach, Sivem [1 ]
Le Cleach, Laurence [1 ,2 ]
Sbidian, Emilie [1 ,2 ]
机构
[1] Univ Paris Est Creteil, UPEC EpiDermE EA, Creteil, France
[2] UPEC, Hop Univ Henri Mondor, AP HP, Dept Dermatol, Creteil, France
关键词
D O I
暂无
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
32102
引用
收藏
页码:AB103 / AB103
页数:1
相关论文
共 50 条
  • [31] Assessing the Short-Term Efficacy and Safety of Guselkumab for Moderate-to-Severe Plaque Psoriasis: Meta-Analysis of Randomized Controlled Trials
    Yang, Jing
    Wang, Zongming
    Zhang, Xilin
    JOURNAL OF IMMUNOLOGY RESEARCH, 2020, 2020
  • [32] Pattern of response in patients with moderate-to-severe psoriasis treated with etanercept
    Griffiths, C. E. M.
    Sterry, W.
    Brock, F.
    Dilleen, M.
    Stefanidis, D.
    Germain, J. M.
    Mallbris, L.
    BRITISH JOURNAL OF DERMATOLOGY, 2015, 172 (01) : 230 - 238
  • [33] Influence of Genetic Polymorphisms on Response to Biologics in Moderate-to-Severe Psoriasis
    Membrive Jimenez, Cristina
    Perez Ramirez, Cristina
    Sanchez Martin, Almudena
    Vieira Maroun, Sayleth
    Arias Santiago, Salvador Antonio
    Ramirez Tortosa, Maria del Carmen
    Jimenez Morales, Alberto
    JOURNAL OF PERSONALIZED MEDICINE, 2021, 11 (04):
  • [34] Predictors of response to tildrakizumab for moderate-to-severe chronic plaque psoriasis
    Blauvelt, Andrew
    Reich, Kristian
    Papp, Kim A.
    Tyring, Stephen K.
    Sinclair, Rodney
    Thaci, Diamant
    Gooderham, Melinda
    Li, Qing
    Cichanowitz, Nicole
    la Rosa, Carmen
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 79 (03) : AB226 - AB226
  • [35] Polymorphisms associated with etanercept response in moderate-to-severe plaque psoriasis
    Ovejero-Benito, Maria C.
    Prieto-Perez, Rocio
    Llamas-Velasco, Mar
    Belmonte, Carmen
    Cabaleiro, Teresa
    Roman, Manuel
    Ochoa, Dolores
    Talegon, Maria
    Saiz-Rodriguez, Miriam
    Dauden, Esteban
    Abad-Santos, Francisco
    PHARMACOGENOMICS, 2017, 18 (07) : 631 - 638
  • [37] Nail psoriasis as a predictor of skin response to ixekizumab in patients with moderate-to-severe psoriasis
    Rich, P.
    Goldblum, O.
    Amato, D.
    Disch, D.
    Muram, D.
    Merola, J. F.
    Elewski, B.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2018, 138 (05) : S67 - S67
  • [38] Patient-reported Outcomes and Clinical Response in Patients with Moderate-to-severe Plaque Psoriasis Treated with Tonsillectomy: A Randomized Controlled Trial
    Thorleifsdottir, Ragna Hlin
    Sigurdardottir, Sigrun Laufey
    Sigurgeirsson, Bardur
    Olafsson, Jon Hjaltalin
    Sigurdsson, Martin Ingi
    Petersen, Hannes
    Gudjonsson, Johann Eli
    Johnston, Andrew
    Valdimarsson, Helgi
    ACTA DERMATO-VENEREOLOGICA, 2017, 97 (03) : 340 - 345
  • [39] Efficacy and safety of vunakizumab in moderate-to-severe chronic plaque psoriasis: A randomized, double-blind, placebo-controlled phase 3 trial
    Yan, Kexiang
    Li, Fuqiu
    Bi, Xiaodong
    Han, Ling
    Zhang, Zhenghua
    Chen, Rixin
    Li, Yuye
    Zhang, Litao
    Wang, Xiaohua
    Li, Linfeng
    Lu, Jianyun
    Xu, Ai'e
    Yang, Sen
    Lu, Yan
    Sun, Jianfang
    Li, Zhiming
    Zhu, Xiaohong
    Jiang, Meiying
    Zhang, Siping
    Wang, Wenqing
    Li, Yanling
    Meng, Zudong
    Li, Hongyi
    Mou, Kuanhou
    Han, Xiuping
    Li, Shanshan
    Chen, Aijun
    Li, Xin
    Liu, Donghua
    Zhang, Chunlei
    Ji, Chao
    Wang, Yu
    Cheng, Hao
    Cui, Xiaojing
    Yao, Xiaoyan
    Bai, Xiaoyan
    Dong, Guangchao
    Xu, Jinhua
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2025, 92 (01) : 92 - 99
  • [40] Efficacy and safety of ixekizumab in a randomized, double-blinded, placebo-controlled phase IIIb study of patients with moderate-to-severe genital psoriasis
    Ryan, C.
    Menter, A.
    Guenther, L.
    Blauvelt, A.
    Bissonnette, R.
    Meeuwis, K.
    Sullivan, J.
    Cather, J. C.
    Yosipovitch, G.
    Gottlieb, A. B.
    Merola, J. F.
    Duffin, K. Callis
    Fretzin, S.
    Osuntokun, O. O.
    Burge, R.
    Naegeli, A. N.
    Yang, F. E.
    Lin, C. -Y.
    Todd, K.
    Bleakman, A. Potts
    BRITISH JOURNAL OF DERMATOLOGY, 2018, 179 (04) : 844 - 852